DOI QR코드

DOI QR Code

Trends in the Korean Government Support for Marine Biotechnology R&D Investment and Its Implication

해양바이오 분야 정부 R&D 지원사업의 동향과 함의

  • Jang, Duckhee (Strategy Section, Ocean Policy Institute, KIOST) ;
  • Doh, Soogwan (Department of Public Administration, College of Social Sciences, Daegu Catholic University)
  • 장덕희 (한국해양과학기술원 해양정책연구소 미래전략실) ;
  • 도수관 (대구가톨릭대학교 사회과학대학 행정학과)
  • Received : 2018.03.07
  • Accepted : 2018.09.09
  • Published : 2018.09.30

Abstract

This study seeks to analyze trends in Korean government support for marine biotechnology R&D investment. The quantitative analysis proposed in this paper provides useful data to inform government policy making decisions in relation to R&D investment in the marine biotechnology. Data used in this study is from NTIS (National Science & Technology Information Service) DB. Empirical results indicate that national R&D investment in the area of marine biotechnology has recently been increased in terms of the number of R&D programs and the amount of R&D investment. The results also show that the R&D programs in the area of marine biotechnology involve various Ministries of the government of Korea, although the Ministry of Oceans and Fisheries (MOF) performed a key role in the R&D investment in the marine biotechnology. Finally, the results of social network analysis in this study reveals that most of the R&D programs in the area of marine biotechnology seeks the development of new materials using unique features of marine bioresources.

Keywords

References

  1. Yonhap News (2017) President Moon Jae-in, opening remarks at the 22nd Marine Day celebration. http://www.yonhapnews.co.kr/bulletin/2017/05/31/0200000000AKR20170531073500001.HTML?input=1195m Accessed 27 Sep 2017
  2. Jang D (2016) A study for establishment of enhancing strategy for marine-bio industry. Marine Biodiversity Institute of KOREA, 84 p
  3. Jang D, Kang Y, Oh C, Doh S (2017) Analysis of biotechnology companies' needs related to supporting their entry into the marine biotechnology industry. Ocean Polar Res 39(3):233-244 https://doi.org/10.4217/OPR.2017.39.3.233
  4. Allen MJ, Jaspars M (2009) Realizing the potential of marine biotechnology: challenges & opportunities. Industr Biot 5(2):77-83 https://doi.org/10.1089/ind.2009.5.077
  5. Carte BK (1996) Biomedical potential of marine natural products. Bioscience 46(4):271-286 https://doi.org/10.2307/1312834
  6. Colwell RR (1984) The industrial potential of marine biotechnology. Oceanus 27(1):3-12
  7. Chesbrough H, Crowther AK (2006) Beyond high tech: early adopters of open innovation in other industries. R&D Management 36(3):229-236 https://doi.org/10.1111/j.1467-9310.2006.00428.x
  8. Dahlander L, Gann DM (2010) How open is innovation? Res Policy 39(6):699-709 https://doi.org/10.1016/j.respol.2010.01.013
  9. Dodgson M, Gann D, Salter A (2006) The role of technology in the shift towards open innovation: the case of Procter & Gamble. R&D Management 36(3):333-346 https://doi.org/10.1111/j.1467-9310.2006.00429.x
  10. El Gamal AA (2010) Biological importance of marine algae. Saudi Pharm J 18(1):1-25 https://doi.org/10.1016/j.jsps.2009.12.001
  11. Enkel E, Gassmann O, Chesbrough H (2009) Open R&D and open innovation: exploring the phenomenon. R&D Management 39(4):311-316 https://doi.org/10.1111/j.1467-9310.2009.00570.x
  12. Fenical W (1997) New pharmaceuticals from marine organisms. Trends Biotechnol 15(9):339-341 https://doi.org/10.1016/S0167-7799(97)01081-0
  13. Fenical W, Jensen PR (2006) Developing a new resource for drug discovery: marine actinomycete bacteria. Nat Chem Biol 2(12):666 https://doi.org/10.1038/nchembio841
  14. Gaffney A (2014) How Many drugs has FDA approved in its entire history? New paper explains. http://www.raps.org/Regulatory-Focus/News/2014/10/03/20488/How-Many-Drugs-has-FDA-Approved-in-its-Entire-History-New-Paper-Explains/ Accessed 10 Sep 2017
  15. Gassmann O, Enkel E (2004) Towards a theory of open innovation: three core process archetypes. In: R&D management conference, Institute of Technology Management with Transfer Center for Technology Management, Lissabon, 7 Jul 2004
  16. GIA (2015) A global strategic business report : marine biotechnology. Global Industry Analysts, San Jose, 246 p
  17. Gordon HS (1954) The economic theory of a common-property resource: the fishery, J Polit Econ 62(2):124-142 https://doi.org/10.1086/257497
  18. Hurst D, Borresen T, Almesjo L, Raedemaecker FD, Bergseth S (2016) Marine biotechnology strategic research and innovation roadmap. MarineBiotech, Oslo, 64 p
  19. Ireland CM, Copp BR, Foster MP, McDonald LA, Radisky DC, Swersey JC (1993) Biomedical potential of marine natural products. In: Attaway DH, Zaborsky OR (eds) Pharmaceutical and bioactive natural products. Springer, Boston, pp 1-43
  20. Killengreen ST, Lecomte N, Ehrich D, Schott T, Yoccoz NG, Ims RA (2011) The importance of marine vs. human-induced subsidies in the maintenance of an expanding mesocarnivore in the arctic tundra. J Anim Ecol 80(5):1049-1060 https://doi.org/10.1111/j.1365-2656.2011.01840.x
  21. OECD (2013) The future of the ocean economy : exploring the prospects for emerging ocean industries to 2030. https://www.oecd.org/futures/The%20Future%20of%20the%20Ocean%20Economy%20Project%20Proposal%20Dec%202013.pdf Accessed 9 May 2017
  22. Peters BG (2006) Concepts and theories of horizontal policy management. In: X Congreso Internacional del CLAD sobre la Reforma del Estado y la Administracion Publica, Chile, 18-21, pp 1-26
  23. Rasmussen RS, Morrissey MT (2007) Marine biotechnology for production of food ingredients. Adv Food Nutrit Res 52:237-292
  24. Rapra S (2015) The future of marine biotechnology for industrial applications to 2025. Smithers Rapra, Market Intelligence. Edt (Smithers Rapra). 95 p
  25. Spolaore P, Joannis-Cassan C, Duran E, Isambert A (2006) Commercial applications of microalgae. J Biosci Bioeng 101(2):87-96 https://doi.org/10.1263/jbb.101.87
  26. Turner JT (2004) The importance of small planktonic copepods and their roles in pelagic marine food webs. Zool Stu 43(2):255-266